TickerFacts.

Insulet Corp (PODD): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.68B
As of 2025-12-31
$1.74B
As of 2026-06-30
-1.9%
3-year compound annual growth
+5.7%
5-year compound annual growth
+21.4%
10-year compound annual growth
$1.88B2010-12-31: $90.00M2011-06-30: $133.31M2011-09-30: $133.56M2011-12-31: $138.59M2012-03-31: $145.46M2012-06-30: $144.59M2012-09-30: $152.93M2012-12-31: $153.88M2013-12-31: $163.36M2014-12-31: $213.35M2015-12-31: $241.07M2016-12-31: $393.50M2017-12-31: $658.23M2018-12-31: $716.60M2019-12-31: $1.07B2020-12-31: $1.27B2021-12-31: $1.49B2022-12-31: $1.77B2023-12-31: $1.86B2024-12-31: $1.88B2025-12-31: $1.68B$1.68B
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.68B-10.7%2026-02-18, Balance as of period end
2024-12-31$1.88B+1.1%2026-02-18, Balance as of period end
2023-12-31$1.86B+4.6%2025-02-21, Balance as of period end
2022-12-31$1.77B+18.9%2024-02-23, Balance as of period end
2021-12-31$1.49B+17.6%2023-02-24, Balance as of period end
2020-12-31$1.27B+19.0%2022-02-24, Balance as of period end
2019-12-31$1.07B+48.9%2021-02-24, Balance as of period end
2018-12-31$716.60M+8.9%2020-02-26, Balance as of period end
2017-12-31$658.23M+67.3%2019-02-26, Balance as of period end
2016-12-31$393.50M+63.2%2018-02-22, Balance as of period end
2015-12-31$241.07M+13.0%2017-02-28, Balance as of period end
2014-12-31$213.35Mn/c2016-02-29, Balance as of period end
2013-12-31$163.36M+6.2%2015-02-26, Balance as of period end
2012-12-31$153.88Mn/a2014-02-28, Balance as of period end
2012-09-30$152.93Mn/a2013-02-28, Balance as of period end
2012-06-30$144.59Mn/a2013-02-28, Balance as of period end
2012-03-31$145.46Mn/a2013-02-28, Balance as of period end
2011-12-31$138.59Mn/a2013-02-28, Balance as of period end
2011-09-30$133.56Mn/a2013-02-28, Balance as of period end
2011-06-30$133.31Mn/a2013-02-28, Balance as of period end
2010-12-31$90.00Mn/a2013-02-28, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Insulet Corp (PODD)2025-12-31$1.68B-10.7%
Globus Medical Inc (GMED)2025-12-31$729.51M-32.1%
West Pharmaceutical Services Inc (WST)2025-12-31$1.09B+13.8%
MiniMed Group, Inc. (MMED)2026-04-24$1.02B+17.0%
Teleflex Inc (TFX)2025-12-31$3.82B+35.6%
Integra Lifesciences Holdings Corp (IART)2025-12-31$2.56B+2.7%
Dexcom Inc (DXCM)2025-12-31$3.59B-18.0%
Merit Medical Systems Inc (MMSI)2025-12-31$1.10B+6.0%
Penumbra Inc (PEN)2025-12-31$398.92M+4.4%

Compare PODD, GMED, WST, MMED side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗